Redmile Group, LLC Lava Therapeutics Nv Transaction History
Redmile Group, LLC
- $1.53 Billion
- Q2 2024
A detailed history of Redmile Group, LLC transactions in Lava Therapeutics Nv stock. As of the latest transaction made, Redmile Group, LLC holds 2,074,372 shares of LVTX stock, worth $3.57 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
2,074,372
Previous 2,074,372
-0.0%
Holding current value
$3.57 Million
Previous $6.91 Million
45.95%
% of portfolio
0.24%
Previous 0.27%
Shares
3 transactions
Others Institutions Holding LVTX
# of Institutions
26Shares Held
3.76MCall Options Held
85.8KPut Options Held
36.8K-
Bruce & Co., Inc. Chicago, IL772KShares$1.33 Million0.68% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L3368KShares$632,2410.1% of portfolio
-
Two Sigma Investments, LP New York, NY112KShares$193,3950.0% of portfolio
-
Alpha Wave Global, LP New York, NY87.4KShares$150,3220.08% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il66.2KShares$113,9270.0% of portfolio
About LAVA Therapeutics NV
- Ticker LVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,797,700
- Market Cap $44.4M
- Description
- LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...